Published Date: 03/31/2022
Expiration Date: 02/16/2025
This course will ensure that clinicians know the prevalence and risk factors for Non-Alcoholic Fatty Liver Disease NAFLD and Non-Alcoholic Steatohepatitis (NASH) in PLWH, the screening protocols and riskof progression of NASH-related liver fibrosis in PLWH, lessons learned from NASH clinical trials in non-HIV patients and the therapeutic landscape for NASH in PLWH.
Meena Bansal, MD is tenured Professor of Medicine and NIH funded investigator with a long-standing interest in studying molecular mechanisms of liver fibrosis in Persons Living with HIV (PWH) as well as those without HIV. She has served as the Principal Investigator for numerous clinical trials for NASH, has developed a screening protocol and database for HIV patients with NAFLD/NASH, and is now launching and leading the NASH Center of Excellence at Mount Sinai. The Center will focus on patient identification, care standardization, risk stratification including predictive algorithms, and translational and clinical research.